Image

Study of rTMS Analgesic Effect in Chronic Neuropathic Pain,

Study of rTMS Analgesic Effect in Chronic Neuropathic Pain,

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to compare the analgesic effectiveness of three modes of repetitive Transcranial Magnetic Stimulation (rTMS) in chronic neuropathic pain:

  • Classical rTMS stimulation
  • Deeper rTMS stimulation
  • Sham rTMS stimulation

Description

Conduct of study:

  • Entry into the study: After informed consent, patients will be randomised. The physician responsible for conducting neurostimulation sessions will make the randomization via an interactive web response system (IWRS). Only this physician will have the knowledge of the group allocated to the patient.
  • Baseline : Patients, will record on a diary form, a daily Visual Numeric Scale(VNS) of Pain Intensity for 1 week.
  • Treatment sessions: after the baseline, sessions of neurostimulation will begin for seven weeks.
  • After the end of neurostimulation sessions, patients will be followed for 2 weeks.
  • Throughout their participation in the study, patients will plot on a diary form their daily VNS.

Eligibility

Inclusion Criteria:

  • Patient's written consent
  • Affiliated with social security system
  • Male or female, suffering for more than a year from unilateral refractory neuropathic pain: hemi-body, upper limb, lower limb and facial chronic pain.
  • Patient whose analgesic treatment, is stable for at least 1 month.
  • Patient not responding to conventional treatments
  • Prescreening EVN >3

Exclusion Criteria:

  • History of drug addiction, epilepsy, cranial trauma
  • History of psychiatric disorder
  • Patients previously treated with rTMS
  • Patient with intracranial ferromagnetic material or implanted stimulator
  • New treatment for less than one month
  • Pregnant or Breastfeeding woman
  • Patient who does not understand the study protocol
  • Persons who are protected under the act.

Study details
    Chronic Neuropathic Pain

NCT04936646

University Hospital, Grenoble

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.